Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Tuberculosis in allogeneic haematopoietic stem cell transplantation: so many unresolved questions!

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    Yoo JW, Jo KW, Kim SH, Lee SO, Kim JJ, Park SK, et al. Incidence, characteristics, and treatment outcomes of mycobacterial diseases in transplant recipients. Transpl Int. 2016;29:549–58.

    Article  Google Scholar 

  2. 2.

    Aki SZ, Sucak GT, Tunccan OG, Kokturk N, Senol E. The incidence of tuberculosis infection in hematopoietic stem cell transplantation recipients: a retrospective cohort study from a center in Turkey. Transpl Infect Dis. 2018;20:e12912.

    Article  Google Scholar 

  3. 3.

    Lee HJ, Lee DG, Choi SM, Park SH, Cho SY, Choi JK, et al. The demanding attention of tuberculosis in allogeneic hematopoietic stem cell transplantation recipients: high incidence compared with general population. PLoS ONE. 2017;12:e0173250.

    Article  Google Scholar 

  4. 4.

    Cordonnier C, Martino R, Trabasso P, Held TK, Akan H, Ward MS, et al. Mycobacterial infection: a difficult and late diagnosis in stem cell transplant recipients. Clin Infect Dis. 2004;38:1229–36.

    CAS  Article  Google Scholar 

  5. 5.

    de la Cámara R, Martino R, Granados E, Rodriguez-Salvanés FJ, Rovira M, Cabrera R, et al. Tuberculosis after hematopoietic stem cell transplantation: incidence, clinical characteristics and outcome. Spanish Group on Infectious Complications in Hematopoietic Transplantation. Bone Marrow Transpl. 2000;26:291–8.

    Article  Google Scholar 

  6. 6.

    Fan W-C, Liu C-J, Hong Y-C, Feng J-Y, Su W-J, Chien S-H, et al. Long-term risk of tuberculosis in haematopoietic stem cell transplant recipients: a 10-year nationwide study. Int J Tuberc Lung Dis. 2015;19:58–64.

    Article  Google Scholar 

  7. 7.

    Zeng QZ, Zhang YY, Wu YJ, Zhang ZY, Zhang JN, Fu HX, et al. Frequency, risk factors, and outcome of active tuberculosis following allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transpl. 2020;26:1203–09.

    CAS  Article  Google Scholar 

  8. 8.

    Agrawal N, Aggarwal M, Kapoor J, Ahmed R, Shrestha A, Kaushik M, et al. Incidence and clinical profile of tuberculosis after allogeneic stem cell transplantation. Transpl Infect Dis. 2018;20:e12794 https://doi.org/10.1111/tid.12794.

    Article  Google Scholar 

  9. 9.

    Mamishi S, Pourakbari B, Moradzadeh M, van Leeuwen WB, Mahmoudi S. Prevalence of active tuberculosis infection in transplant recipients: A systematic review and meta-analysis. Microb Pathog. 2020;139:103894.

    CAS  Article  Google Scholar 

  10. 10.

    World Health Organization. Latent tuberculosis infection: updated and consolidated guidelines for programmatic management. WHO reference number: WHO/CDS/TB/20184 2018.

  11. 11.

    De Oliveira e Souza M, de Almeida Testa, dos Santos ACF, Zanetti LP, de Silva Ruiz Menezes L, de Souza MP, et al. Latent and active tuberculosis infection in allogeneic hematopoietic stem cell transplant recipients: a prospective cohort study. Bone Marrow Transplant. 2021

  12. 12.

    Tomblyn M, Chiller T, Einsele H, Gress R, Sepkowitz K, Storek J, et al. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant. 2009;15:1143–238.

    CAS  Article  Google Scholar 

  13. 13.

    Moon SM, Lee SO, Choi SH, Kim YS, Woo JH, Yoon DH, et al. Comparison of the QuantiFERON-TB Gold In-Tube test with the tuberculin skin test for detecting latent tuberculosis infection prior to hematopoietic stem cell transplantation. Transpl Infect Dis. 2013;15:104–9.

    CAS  Article  Google Scholar 

  14. 14.

    Sester M, van Leth F, Bruchfeld J, Bumbacea D, Cirillo DM, Dilektasli AG, et al. Risk assessment of tuberculosis in immunocompromised patients. A TBNET study. Am J Respir Crit Care Med. 2014;190:1168–76.

    Article  Google Scholar 

  15. 15.

    Lee YM, Lee SO, Choi SH, Kim YS, Woo JH, Kim DY, et al. A prospective longitudinal study evaluating the usefulness of the interferon-gamma releasing assay for predicting active tuberculosis in allogeneic hematopoietic stem cell transplant recipients. J Infect. 2014;69:165–73.

    Article  Google Scholar 

  16. 16.

    Bumbacea D, Arend SM, Eyuboglu F, Fishman JA, Goletti D, Ison MG, et al. The risk of tuberculosis in transplant candidates and recipients: a TBNET consensus statement. Eur Respir J. 2012;40:990–1013.

    Article  Google Scholar 

  17. 17.

    Cheng MP, Kusztos AE, Bold TD, Ho VT, Glotzbecker BE, Hsieh C, et al. Risk of latent tuberculosis reactivation after hematopoietic cell transplantation. Clin Infect Dis. 2019;69:869–72.

    Article  Google Scholar 

  18. 18.

    Bourlon C, Camacho-Hernández R, Fierro-Angulo OM, Acosta-Medina AA, Bourlon MT, Niembro-Ortega MD, et al. Latent tuberculosis in hematopoietic stem cell transplantation: diagnostic and therapeutic strategies to prevent disease activation in an endemic population. Biol Blood Marrow Transplant. 2020;26:1350–4.

    Article  Google Scholar 

  19. 19.

    Budak-Alpdogan T, Tangün Y, Kalayoglu-Besisik S, Ratip S, Akan H, Baslar Z, et al. The frequency of tuberculosis in adult allogeneic stem cell transplant recipients in Turkey. Biol Blood Marrow Transplant. 2000;6:370–4.

    CAS  Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Anne Bergeron.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Bergeron, A. Tuberculosis in allogeneic haematopoietic stem cell transplantation: so many unresolved questions!. Bone Marrow Transplant 56, 2050–2051 (2021). https://doi.org/10.1038/s41409-021-01381-z

Download citation

Search

Quick links